JAGX
NASD Jaguar Health, Inc.$3.95 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.95
- YTD change
- -99.19%
- vs 20-day SMA
- -42.86%
- vs 200-day SMA
- -97.78%
Price ranges
Price & Performance
+3.55 (+887.50%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $7,205,620.00
- JAGX is down 99% since the beginning of the year
- JAGX is down 100% over the past 12 months
- JAGX is down 64% over the past 1 month
- 17% of all JAGX investors are betting against JAGX
JAGX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +78.7%.
- Previous minute
- +$0.00
- Last hour
- -$0.00
- Last 5 days
- -44.05%
- vs 8-day SMA
- -59.45%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the following segments: Animal Health and Human Health. The Animal Health segment is focused on development and commercialization of prescription and non-prescription products for companion and production animals. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
